Study details
Enrolling now
Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test
Aptitude Medical Systems
NCT IDNCT06744660ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,000
Study length
about 1.1 years
Ages
2+
Locations
3 sites in AL, LA
What this study is about
Researchers are testing a test to detect COVID-19. The test will be used in home settings, and it's being evaluated for accuracy compared to an FDA-cleared assay. The trial will take place at multiple sites across the United States.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Aptitude Medical Systems Metrix COVID Test
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
diagnostic
Body systems
Infectious